Advertisement

Journal of Infection and Chemotherapy

, Volume 3, Issue 3, pp 164–169 | Cite as

Myeloperoxidase fragments reacting with serum from a patient with myeloperoxidase-anti-neutrophil cytoplasmic antibody-positive glomerulonephritis

  • Isao Otani
  • Akiko Ishida-Okawara
  • Satoshi Yamagoe
  • Toshiko Miyoshi-Koshio
  • Yoshihiro Arimura
  • Toshihiko Nagasawa
  • Satoshi Mizuno
  • Kazuo Suzuki
Original Articles

Abstract

Myeloperoxidase (MPO) participates in the protection against bacterial infections. This molecule is recognized with an autoantibody, P-ANCA (antineutrophil cytoplasmic antibody with a perinuclear staining pattern). It has been widely detected in certain diseases including vasculitis and crescentic glomerulonephritis. We describe the epitope of MPO recognized by the antibody. Four sera, which were selected from 75 MPO-ANCA positive sera, reacted with the large 59-kDa subunit of MPO, but not with the small 14-kDa subunit. One of the 4 sera reacted with 55-kDa, 34-kDa and 19-kDa deglycosylated forms derived from the 59-kDa large subunit of MPO by treatment with endoglycosidase-H (Endo-H). This serum did not react with 38-kDa or 23-kDa peptides from the large subunit which had not undergone Endo-H treatment, whereas 42-kDa and 40-kDa peptides treated with or without Endo-H, or with heat and nagase, weakly reacted with the serum. These results suggest that the recognition site in the MPO molecule by an anti-MPO serum is adjacent to sites of sugar attachment, which are located on the periphery in the upstream of Mef409 of the large MPO subunit.

Key words

neutrophils myeloperoxidase autoantibodies to neutrophil glomerulonephritis chronic rheumatoid arthritis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yamamoto K, Miyoshi-Koshio T, Utsuki Y, Mizun S, Suzuki K. Virucidal activity and viral protein modification by myeloperoxidase: a candidate for defense factor of human polymorphonuclear leukocytes against influenza virus infection. J Infect Dis 1991;164:8–14.PubMedGoogle Scholar
  2. 2.
    Klebanoff SJ, Coombes RW. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1: role of the myeloperoxidase system. J Clin Invest 1992;89:2014–2017.PubMedGoogle Scholar
  3. 3.
    Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J 1982;285:606.CrossRefGoogle Scholar
  4. 4.
    van Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Goessen M, van der Hem GK, The TH. Autoantibodies against neutrophils and monocytes: tools for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;I:425–429.Google Scholar
  5. 5.
    Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, Koolen JI, Hene RJ, The TH, van der Hem GK, von dem Borne AEGKr, Kallenberg CGM. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990;33:1264–1272.CrossRefGoogle Scholar
  6. 6.
    Savaga COS, Winearls CG, Jones SJ, Marshall PD, Lockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1987;1:1389–1393.CrossRefGoogle Scholar
  7. 7.
    Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. New Engl J Med 1988;318:1651–1657.PubMedCrossRefGoogle Scholar
  8. 8.
    Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AEGKr, Kallenberg CGM. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799–806.Google Scholar
  9. 9.
    Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K, Kitamoto K, Nagasawa T. A case of Goodpasture's syndrome associated with anti-myeloperoxidase antibodies. Intern Med 1992;31:239–243.PubMedGoogle Scholar
  10. 10.
    Arimura Y, Minoshima S, Kamiya Y, Nakabayashi K, Kitamoto K, Nagasawa T, Sasaki T, Suzuki K. Serum myeloperoxidase and serum cytokines in a anti-myeloperoxidase antibody associated glomerulonephritis. Clin Nephrol 1993;40:256–264.PubMedGoogle Scholar
  11. 11.
    Lassoued S, Sixou L, Oksman F, Pages M, Fournie A. Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis. Arthritis Rheum 1991;34:1069–1070.PubMedGoogle Scholar
  12. 12.
    Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EA, Kleijburg-van der Keur C, Breedveld FC. Antilactoferrin antibodies are associated with vasculitis. Arthritis Rheum 1992;35:1466–1475.PubMedGoogle Scholar
  13. 13.
    Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202–210.PubMedCrossRefGoogle Scholar
  14. 14.
    Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Grunfeld JP, Lesavre P. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1992;90:79–84.PubMedCrossRefGoogle Scholar
  15. 15.
    Saeki T, Kuroda T, Morita T, Suzuki K, Arakawa M, Kawasaki K. Significance of myeloperoxidase in rapidly progressive glomerulonephritis. Am J Kidney Dis 1995;26: 13–21.PubMedGoogle Scholar
  16. 16.
    Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989;74:1888–1893.PubMedGoogle Scholar
  17. 17.
    Goldschmeding R, van der Schoot CE, ten Bokkel Huinink D, Hack CE, van den Ende ME. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84:1577–1587.PubMedCrossRefGoogle Scholar
  18. 18.
    Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL. Wegener's autoantigen decoded. Nature 1990;346:520.PubMedCrossRefGoogle Scholar
  19. 19.
    Jenette JC, Hoidal JR, Falk RJ. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 1990;75:2263–2265.Google Scholar
  20. 20.
    Thompson RA, Lee SS. Antineutrophil cytoplasmic antibodies. Lancet 1989;1:670–671.PubMedCrossRefGoogle Scholar
  21. 21.
    Braun MG, Csernok E, Schmitt W, Jaiscjo DS, Gross WL. Anti-neutrophil antibodies (ANCA) and extra-articular involvement in rheumatoid arthritis (RA). Clin Exp Immunol 1993;93(suppl 1):33.Google Scholar
  22. 22.
    Nassberger L, Ljungh A, Schumacher G, Lollberg B. Betaglucuronidase antibodies in ulcerative colitis. Lancet 1992; 340:734–735.PubMedCrossRefGoogle Scholar
  23. 23.
    Dolman KM, Goldschmeding R, Sonnenberg A, von dem Borne AEGKr. ANCA related antigens. AMPIS 1990; (suppl 19):28.Google Scholar
  24. 24.
    Short AK, Lockwood CM, Bollen A, Moguilevsky N. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis. Clin Exp Immunol 1995;102:106–111.PubMedCrossRefGoogle Scholar
  25. 25.
    Chang L, Binos S, Savige J. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Clin Exp Immunol 1995;102:112–119.PubMedCrossRefGoogle Scholar
  26. 26.
    Homma T, Suzuki K, Kudo Y, Inagawa M, Mizuno S, Yamaguchi E, Tagawa M. Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch Biochem Biophys 1989;273:189–196.PubMedCrossRefGoogle Scholar
  27. 27.
    Ishida-Okawara A, Kimoto Y, Watanabe K, Tokuda K, Shibata M, Masuda K, Takano Y, Kawaguchi K, Akagawa H, Nilubol H, Hotta K, Yazawa K, Mizuno S, Suzuki K. Purification and characterization of aseanostatins: actinomycete-derived fatty acid inhibitors to myeloperoxidase release from human polymorphonuclear leukocytes. J Antibiotics 1991;44:524–532.Google Scholar
  28. 28.
    Laemli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.CrossRefGoogle Scholar
  29. 29.
    Taylor KL, Pohl J, Kinkade JM Jr. Unique autolytic cleavage of human myeloperoxidase. Implications for the involvement of active site MET409. J Biol Chem 1992;267:25282–25288.PubMedGoogle Scholar

Copyright information

© JSC/CLJ 1997

Authors and Affiliations

  • Isao Otani
    • 1
    • 2
  • Akiko Ishida-Okawara
    • 1
  • Satoshi Yamagoe
    • 1
  • Toshiko Miyoshi-Koshio
    • 1
  • Yoshihiro Arimura
    • 3
  • Toshihiko Nagasawa
    • 3
  • Satoshi Mizuno
    • 1
  • Kazuo Suzuki
    • 1
  1. 1.Department of Bioactive MoleculesNational Institute of Infectious DiseasesTokyoJapan
  2. 2.Department of Veterinary Pathology IINihon UniversityTokyoJapan
  3. 3.First Department of Internal MedicineKyorin UniversityTokyoJapan

Personalised recommendations